Sign Up to like & get
recommendations!
0
Published in 2018 at "Advances in Therapy"
DOI: 10.1007/s12325-018-0696-y
Abstract: IntroductionA large, statewide, fee-for-service Medicaid plan recently (October 2015) executed a complete switch from sublingual buprenorphine–naloxone [(SLBN), Suboxone®] to buccal buprenorphine–naloxone [(BBN), Bunavail®] on its preferred drug formulary. This complete formulary switch provided an opportunity…
read more here.
Keywords:
buprenorphine naloxone;
medicaid plan;
buprenorphine;
state medicaid ... See more keywords